Abstract

Microscale technology has been increasingly used in chemical synthesis up to production scale, but in biocatalysis the implementation has been proceeding at a slower pace. In this work, the design of a low cost and versatile continuous flow enzyme microreactor is described that illustrates the potential of microfluidic reactors for both the development and characterization of biocatalytic processes. The core structure of the developed reactor consists of an array of capillaries with 450 μm of inner diameter with their inner surface functionalized with (3-aminopropyl)triethoxysilane (APTES) and glutaraldehyde where Saccharomyces cerevisiae invertase was covalently bound. The production of invert sugar syrup through enzymatic sucrose hydrolysis was used as model system. Once the microreactor assembly reproducibility and the immobilized enzyme behavior were established, the evaluation of the immobilized enzyme kinetic parameters was carried out at flow rates ranging from 20.8 to 219.0 μL·min−1 and substrate concentrations within 2.0%–10.0% (w/v). Despite the impact of immobilization on the kinetic parameters, viz. Km(app) was increased two fold and Kcat showed a 14-fold decrease when compared to solution phase invertase, the immobilization proved highly robust. For a mean residence time of 48.8 min, full conversion of 5.0% (w/v) sucrose was observed over 20 days.

Highlights

  • IntroductionThe use of microscale technology in chemical synthesis, biomedical devices, analytics and point of care diagnostic systems has long been established and continuous to grow at great pace [1,2,3,4,5,6]

  • The use of microscale technology in chemical synthesis, biomedical devices, analytics and point of care diagnostic systems has long been established and continuous to grow at great pace [1,2,3,4,5,6].This fact is due to the high set of benefits that arise from the use of microscale platforms both at the product development and production stages

  • Microreactors have already become a key component in chemical synthesis, yet its potential in biocatalysis, with the exception to the microwell format in process development, has not been fully capitalized, their application in some relevant reaction systems supports the validity of the approach [11]

Read more

Summary

Introduction

The use of microscale technology in chemical synthesis, biomedical devices, analytics and point of care diagnostic systems has long been established and continuous to grow at great pace [1,2,3,4,5,6] This fact is due to the high set of benefits that arise from the use of microscale platforms both at the product development and production stages. Microreactors have already become a key component in chemical synthesis, yet its potential in biocatalysis, with the exception to the microwell format in process development, has not been fully capitalized, their application in some relevant reaction systems supports the validity of the approach [11]. On the quest for high performance/sustainable manufacturing technologies, the combination of biocatalysis and microscale technology display a wide set of appealing features and new opportunities worth to embrace, such as the separation of unstable intermediates from the reaction media [7,9,10,12]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.